Effectiveness of robotic-assisted walking (lokomat) on quality of life
Effectiveness of robotic-assisted walking (lokomat) on quality of life, gait, activity level, and balance in patients with multiple sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What it measured
Main measures
1. Quality of life will be measured at baseline, at discharge (three weeks) and at 3 and 12 months 2. Activity level will be measured during seven days before the rehabilitation, in the middle week of the rehabilitation, and 3 and 12 months after discharge of rehabilitation 3. Gait-parameters (symmetry, gait security, gait speed, gait capacity) will be measured only during rehabilitation setting (
Walking and mobilityQuality of life (reported by participants)
Other measures (1)
1. Pain will be measured at baseline, before and after gait interventions (each time), each day in the evening, at three weeks (discharge rehabilitation), 3 and 12 months post rehabilitation 2. Fatique will be measured at baseline, before and after gait interventions (each time), each day in the evening, at three weeks (discharge rehabilitation), 3 and 12 months post rehabilitation 3. Spasticity w
Walking and mobilitySpasticityPain
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
Inclusion: 1. Aged 18 or older 2. Diagnosed with multiple sclerosis confirmed by a specialist in neurology by the mean of the McDonald criteria 3. EDSS score equal or higher than 3 and lower or equal than 7.0 4. Able to walk 14 metres (with or without assistive devices) 5. Willingness to comply with any programme to which randomly assigned Exclusion: 1. Disorders preventing active rehabilitation (cardiovascular, respiratory, orthopaedic, psychiatric, or other medical conditions, including unhealed decubitus and orthostatic hypotension; pregnancy) 2. Rehabilitation period planned of less than three weeks 3. One or more exacerbations in the preceding three months 4. More than 135 kg 5. Strong asymmetry of musculoskeletal system 6. Length of femur less than 34 cm
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Not provided at time of registration
Papers
Loading reviews and guidelines…
History
Started
Apr 2007
Finished
Sept 2010